Cellebrite DI (CLBT) — Cash Flow Reinvestment Rate
Cellebrite DI (CLBT) has a Cash Flow Reinvestment Rate of 1.20x as of December 2025, reinvesting $98.66 Million (capex $3.96 Million plus investments $-94.70 Million) from operating cash flow of $82.23 Million. Explore Cellebrite DI (CLBT) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cellebrite DI Cash Flow Reinvestment Rate (2019–2025)
Historical reinvestment intensity for Cellebrite DI across 7 annual periods. Also explore Cellebrite DI assets under control for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Cellebrite DI (2019–2025)
Year-by-year capital reinvestment analysis for Cellebrite DI. For live market cap and broader valuation context, see CLBT market cap.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.71x | $120.79 Million | $168.96 Million | $13.22 Million | ▼ -41.0% |
| 2024 | 1.21x | $160.08 Million | $132.17 Million | $10.61 Million | ▲ +73.9% |
| 2023 | 0.70x | $71.06 Million | $102.06 Million | $7.92 Million | ▼ -85.7% |
| 2022 | 4.88x | $100.32 Million | $20.58 Million | $9.09 Million | ▲ +115.8% |
| 2021 | 2.26x | $81.45 Million | $36.05 Million | $8.11 Million | ▲ +616.9% |
| 2020 | 0.32x | $20.96 Million | $66.51 Million | $6.18 Million | ▼ -89.1% |
| 2019 | 2.90x | $46.72 Million | $16.13 Million | $6.21 Million | — |